MicroRNA Expression in Human Blood Serum and Vitreous Body
NCT ID: NCT01462734
Last Updated: 2015-04-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
8 participants
OBSERVATIONAL
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MicroRNA Expression Profile in Human Vitreous of Patients With Various Vitreoretinal Diseases Requiring Vitrectomy
NCT01674023
Analysis of Biomarkers From Patients With Chorioretinal Diseases
NCT02026843
Macular Retinoschisis and Detachment Associated With Glaucomatous Optic Neuropathy
NCT01862627
Treatment Trial for Acute Central Serous Chorioretinopathy
NCT02784665
Retina Projection System Trials for Low Vision People
NCT00219427
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
human vitreous, human blood serum, PCR
Vitreous and bloodserum samples from macula hole patients without previous ocular or systemic disease
human vitreous and blood serum sampling, PCR
1ml of human vitreous and 3ml of human blood serum
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
human vitreous and blood serum sampling, PCR
1ml of human vitreous and 3ml of human blood serum
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kyorin University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kazunari Hirota
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kyorin University School Of Medicine
Tokyo, Mitakasi Sinkawa6-20-2, Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
No. 461
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.